Biomedical and health research: an analysis of country participation and research fields in the EU’s Horizon 2020

Abstract

We analysed the Horizon 2020 project database, currently the European Union’s (EU) largest framework programme for research and innovation—nearly 80 billion euros available over 7 years (2014–2020), to estimate the amount and type of EU-supported biomedical and health research and funding distribution among EU member states and non-European countries. Out of 20,877 projects as of 14th January 2019, a total of 4865 projects were classified as human health related. Ninety-four countries/territories worldwide participated in at least one biomedical project. The EU-15 original member states showed the highest participation as project leaders/partners and for acquired funding. Strong unequal funding distribution and participation between EU-15 and the 13 newest members—with EU-15 receiving about 87% of funding and EU-13 only 3%—have been evidenced. For both EU-15 and EU-13 we detected about 20% of projects involving the public and private sectors, according to Horizon 2020 guidelines. The largest percentage of projects was in the areas of biotechnological research (28.28%) and “basic research” (26.95%); these two sectors together accounted for 46.99% of the total funding assigned (7.9 billion euros). Research in neurosciences and neurological diseases appeared to be an increasing study area. Neurological and mental diseases covered about 21% of projects. Epidemiological studies accounted for about 5% of the total projects and for 14% of funding. Strong correlations were shown by indicators of financial and scientific capacity to identify success rates in obtaining EU funding, making the gap between countries with strong and weak research infrastructures difficult to overcome. Electronic supplementary material The online version of this article (10.1007/s10654-020-00690-9) contains supplementary material, which is available to authorized users.

EU FP7 research funding for an orphan drug (Orfadin®) and vaccine (Hep C) development: a success and a failure?

“…Horizon 2020 (FP8) covers the years 2014–2020 with a budget of 80 billion euros, of which 7.9 billion euros was invested in biomedical and health research projects. The largest percentage of projects was in the areas of biotechnological research and development activities (28.28%) and basic research (26.95%); these two sectors together accounted for 46.99% of the health budget [ 32 ]. Health Europe (FP9) will cover the period 2021–2027.…”

Measuring the AI content of government-funded R&D projects

“…The GtR (Gateway to Research) is a UK funding database containing R&D projects funded by Innovate UK, by the National Centre for the Replacement, Refinement and Reduction of Animals in Research (NC3Rs), and by seven additional research councils. 29…”

“…The data covered 7 177 projects, which received USD 2 186 million between 2016 to 2019. 29 These seven research councils are: 1.…”

“…Some studies have looked at the classification of NIH funding ( (Park et al, 2016[33]) and(Talley et al, 2011[28])), and of NSF funding ((Kawamura et al, 2018[27]) and (Freyman, Byrnes and Alexander, 2016[29])), but none have specifically targeted AI-related research 15. The embedded tagging of available records could be an important source of information.…”

“Rehabilitation Research Framework for Patients With COVID-19” Defined by Cochrane Rehabilitation and the World Health Organization Rehabilitation Programme

“…The CRRF presents the scope and areas of research enquiry that need to be addressed in order to build a comprehensive evidence base for clinical care, service organization, and health system strengthening to meet the needs of COVID-19 patients. Research frameworks have long been used by scientific communities to reflect consensus on research priorities (16)(17)(18), direct research funding (19,20) and drive research efforts (21,22) for entire sectors (23,24) or specific topics and sub specializations, including in rehabilitation (25-28). Reflecting these traditional functions, the CRRF has the specific aims to: This paper presents the methodology used to develop the CRRF, discusses how emerging evidence maps to the CRRF, and proposes how it can be best operationalized to meet its intended aims.…”